FindTrial
Sign In

Laskimonsisäinen PCA (patient-controlled analgesia) -oksikodoni verrattuna suun kautta otettavaan oksikodoniin keisarileikkauksen jälkeisen kivun lievityksessä – satunnaistettu vertaileva tutkimus

Laskimonsisäinen PCA (patient-controlled analgesia) -oksikodoni verrattuna suun kautta otettavaan oksikodoniin keisarileikkauksen jälkeisen kivun lievityksessä – satunnaistettu vertaileva tutkimus

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2014-001705-40-FI
Enrollment
800
Registered
2015-02-06
Start date
2015-02-09
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 17.1 Level: PT Classification code 10006924 Term: Caesarean section System Organ Class: 10042613 - Surgical and medical procedures

Interventions

Trade Name: Oxanest Product Name: Oxanest Pharmaceutical Form: Infusion INN or Proposed INN: oxycodoni hydrochloridum CAS Number: 124-90-3 Other descriptive name: OXYCODONE HYDROCHLORIDE Concentration

Sponsors

Tampereen yliopistollinen sairaala
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 800 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Contacts

Public ContactProfessori Jukka Uotila

Tampereen yliopistollinen sairaala

jukka.uotila@pshp.fi

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026